GO
Loading...

Enter multiple symbols separated by commas

Shire says ready to recommend higher AbbVie offer

Shire said on Monday it was ready to recommend a newly revised higher offer from AbbVie, valuing the London-listed drugmaker at £53.20 pounds ($90.53) per share.

AbbVie, which wants to buy Shire to cut its tax bill and diversify its product line-up, raised its cash-and-stock offer for Shire to £51.15 a share last Tuesday.

Read MoreUK to demand job assurances in foreign takeovers

On Monday the firm said it had requested and received a higher proposal comprising £24.44 in cash and 0.8960 shares of new AbbVie per Shire share.

Under the offer, Shire shareholders would own approximately 25 percent of the combined new firm.

Follow us on Twitter: @CNBCWorld

Contact Europe News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Europe Video

  • Mayweather vs. Pacquiao on social media

    James Cuthbertson, global sales director at Pulsar & FACE, talks about what happens on social media platforms when it comes to events like the Pacquiao vs. Mayweather boxing fight last weekend.

  • Hung parliament looms for UK

    John Authers, senior investment commentator at the Financial Times newspaper, says that any alternative to a hung parliament in the U.K. would be "remarkable."

  • UK election: What really matters

    What will really matter to Britons when they vote on Thursday? John Authers, senior investment commentator at the Financial Times newspaper, says it's the economy.